Company intelligence / Profile preview

Maxi Health

Brooklyn, New York, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Maxi Health commercializes over 130 nutritional supplements, primarily targeting wellness, preventative health, and condition-specific needs, with a focus on kosher-certified products. Formulas emphasize bioavailability, purity, and efficacy based on decades of research and rigorous scientific testing. No clinical trial data available; marketed as dietary supplements, not therapeutics.

Therapeutic areas: CardiovascularImmunologyEndocrinologyRheumatologyGastroenterologyWomen's HealthOtherPsychiatry
Modalities: Nutritional supplementHerbal extractProteinProbioticVitaminMineral
Industry: Food & Nutrition

Partnerships

Wakunaga of America Inc. (Kyolic Aged Garlic products)

Beyond the preview

Go deeper on Maxi Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maxi Health.

Explore the full profile